Byers V S, Johnston J O
Cancer Res. 1977 Sep;37(9):3173-83.
Sections were taken from the center, midzone, and margin of four human osteogenic sarcomas and one fibrosarcoma. Single-cell suspensions of tumors were examined in an indirect immunofluorescence assay with autologous or homologous anti-osteogenic sarcoma antisera as the intermediate reactant and fluorescein-labeled anti-human IgG as the final reactant. Cells were stained under conditions in which the fluorescence intensity was directly proportional to the density of the tumor-associated antigen on these cells. The density of tumor-associated antigen on cells from the center of the five tumor masses was low; cells from the midzone had intermediate levels of tumor antigen density, and cells at the margin had the highest levels. Similar preparations stained with polyspecific anti-HLA antisera did not demonstrate such a gradient. Since osteogenic sarcomas grow outward from the center, with the outer margin populated by the youngest cells, these results suggest that the oldest cells in the tumor bear the least tumor antigen, and the youngest tumor cells have the most. This is not compatible with theories which postulate that the immune system modulates the growth of a tumor so that only the least antigenic cells are allowed to grow. Alternative mechanisms are discussed.
从4例人类骨肉瘤和1例纤维肉瘤的中心、中间区域和边缘取材。肿瘤的单细胞悬液在间接免疫荧光试验中进行检测,以自体或同种抗骨肉瘤抗血清作为中间反应物,以荧光素标记的抗人IgG作为最终反应物。在荧光强度与这些细胞上肿瘤相关抗原密度成正比的条件下对细胞进行染色。5个肿瘤块中心的细胞上肿瘤相关抗原密度低;中间区域的细胞肿瘤抗原密度处于中等水平,边缘的细胞肿瘤抗原密度最高。用多特异性抗HLA抗血清染色的类似标本未显示出这种梯度。由于骨肉瘤从中心向外生长,最外层边缘由最年轻的细胞构成,这些结果表明肿瘤中最老的细胞携带的肿瘤抗原最少,而最年轻的肿瘤细胞携带的肿瘤抗原最多。这与假设免疫系统调节肿瘤生长从而只允许抗原性最低的细胞生长的理论不相符。文中讨论了其他机制。